Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras

Area of Science:

• Cell Biology
• Molecular Biology
• Oncology

Background:

• The cell-cycle inhibitor p21 is known to be upregulated during cellular senescence and oncogene-induced arrest.
• Its precise role in these processes, particularly in the absence of p21, remains to be fully elucidated.

Purpose of the Study:

• To investigate the role of p21 in senescence and oncogene-induced arrest using primary fibroblasts from p21-null mice.
• To determine if p21 deficiency alone is sufficient for cellular immortalization.
• To assess the impact of p21 deficiency on preventing neoplastic transformation induced by oncogenic Ras.

Main Methods:

• Utilized primary fibroblasts derived from p21-null mice and wild-type littermates.
• Induced senescence and senescence-like arrest using oncogenic Ras.
• Assessed cellular lifespan, senescence entry, and immortalization potential.
• Analyzed the expression of p53 and p16INK4a.
• Evaluated resistance to neoplastic transformation by oncogenic Ras.

Main Results:

• Primary p21-null fibroblasts exhibited normal senescence and lifespan comparable to wild-type cells.
• Immortalization of both wild-type and p21-null cultures involved alterations in p53 or p16INK4a, not solely p21 deficiency.
• p21-null cells responded to oncogenic Ras by accumulating p53 and p16INK4a and reducing proliferation, similar to wild-type cells.
• p21-null cells were refractory to neoplastic transformation by oncogenic Ras, unlike p53-null cells.

Conclusions:

• p21 is not essential for initiating senescence or for preventing neoplastic transformation in murine fibroblasts.
• p21 deficiency does not bypass the requirement for alterations in p53 or p16INK4a for cellular immortalization.
• These findings clarify the non-essential role of p21 in key tumor suppression pathways in this cellular context.